+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Propylthiouracil"

Anti-Thyroid Drugs Global Market Report 2024 - Product Thumbnail Image

Anti-Thyroid Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
United Arab Emirates Thyroid Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

United Arab Emirates Thyroid Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • United Arab Emirates United Arab Emirates
From
From
From
From
From
From
From
Loading Indicator

Propylthiouracil (PTU) is a medication used to treat hyperthyroidism, a condition in which the thyroid gland produces too much thyroid hormone. It is a thioamide drug, which works by blocking the production of thyroid hormones. PTU is used to treat Graves' disease, an autoimmune disorder that causes hyperthyroidism, as well as other forms of hyperthyroidism. PTU is also used to treat thyroid storm, a rare but serious condition in which the body produces too much thyroid hormone. PTU is part of the Endocrine and Metabolic Disorders Drugs market, which includes medications used to treat a variety of endocrine and metabolic disorders. These drugs are used to treat conditions such as diabetes, obesity, and thyroid disorders. Companies in the Propylthiouracil market include Merck, Pfizer, Sanofi, and Mylan. Show Less Read more